Thyroid Hormone T4 (Thyroxine) Suppression: Revision history

From Glioblastoma Treatments
Jump to navigationJump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

12 November 2024

5 April 2024

27 March 2024

23 March 2024

  • curprev 13:3313:33, 23 March 2024‎ Lazy talk contribs‎ 1,707 bytes +1,707‎ Created page with "{{TreatmentInfo |drug_name=Thyroid Hormone T4 Suppression Therapy |FDA_approval=No (Used off-label for cancer treatment; specific regimen for cancer not FDA-approved) |used_for=Investigational use in cancer treatment, particularly in glioblastoma, based on observations of improved outcomes with hypothyroid status |clinical_trial_phase=Early clinical trials and case studies, including a phase 2 clinical trial in Israel (NCT02654041) |common_side_effects=Carefully monitore..."
Retrieved from "http://glioblastomatreatments.wiki:80/index.php?title=Thyroid_Hormone_T4_(Thyroxine)_Suppression"